Analyzing Ratios: Travere Therapeutics Inc (TVTX)’s Financial Story Unveiled

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

The price of Travere Therapeutics Inc (NASDAQ: TVTX) closed at $15.13 in the last session, up 1.24% from day before closing price of $14.94. In other words, the price has increased by $1.24 from its previous closing price. On the day, 0.78 million shares were traded. TVTX stock price reached its highest trading level at $15.15 during the session, while it also had its lowest trading level at $14.71.

Ratios:

We take a closer look at TVTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.03 and its Current Ratio is at 2.05. In the meantime, Its Debt-to-Equity ratio is 12.20 whereas as Long-Term Debt/Eq ratio is at 9.94.

On June 11, 2025, Citigroup reiterated its Buy rating and also upped its target price recommendation from $35 to $32.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 05 ’25 when Cline Christopher R. sold 1,784 shares for $21.05 per share. The transaction valued at 37,553 led to the insider holds 93,126 shares of the business.

Dube Eric M sold 18,924 shares of TVTX for $398,350 on May 05 ’25. The CHIEF EXECUTIVE OFFICER now owns 419,173 shares after completing the transaction at $21.05 per share. On May 05 ’25, another insider, Heerma Peter, who serves as the CHIEF COMMERCIAL OFFICER of the company, sold 1,771 shares for $21.05 each. As a result, the insider received 37,280 and left with 128,215 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1343616640 and an Enterprise Value of 1421837952. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.91 while its Price-to-Book (P/B) ratio in mrq is 40.93. Its current Enterprise Value per Revenue stands at 5.198 whereas that against EBITDA is -7.961.

Stock Price History:

The Beta on a monthly basis for TVTX is 0.74, which has changed by 0.84063256 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $7.72. The 50-Day Moving Average of the stock is -10.44%, while the 200-Day Moving Average is calculated to be -15.28%.

Shares Statistics:

According to the various share statistics, TVTX traded on average about 1.76M shares per day over the past 3-months and 1516630 shares per day over the past 10 days. A total of 88.79M shares are outstanding, with a floating share count of 87.50M. Insiders hold about 1.47% of the company’s shares, while institutions hold 112.64% stake in the company. Shares short for TVTX as of 1749772800 were 10329311 with a Short Ratio of 5.88, compared to 1747267200 on 10434682. Therefore, it implies a Short% of Shares Outstanding of 10329311 and a Short% of Float of 11.709999999999999.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.